- Fostering Strategic Changes in Publishing: Journal of Korean Medical Science in 2018
-
Hong ST
- KMID: 2399165
- J Korean Med Sci.
- 2018 Jan;33(1):e8.
- doi: 10.3346/jkms.2018.33.e8
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Pediatric Deaths Attributed to Complex Chronic Conditions over 10 Years in Korea: Evidence for the Need to Provide Pediatric Palliative Care
-
Kim MS, Lim NG, Kim HJ, Kim C, Lee JY
- KMID: 2399158
- J Korean Med Sci.
- 2018 Jan;33(1):e1.
- doi: 10.3346/jkms.2018.33.e1
BACKGROUND: Pediatric palliative care (PPC) is the active total care of children suffering from life-threatening illnesses. Palliative care includes symptom management, psychosocial support, and end-of-life care. Despite significant advances in... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report
-
Park CK, Hur JY, Choi CM, Kim TO, Cho HJ, Shin HJ, Lim JH, Choi YD, Kim YC, Oh IJ
- KMID: 2399164
- J Korean Med Sci.
- 2018 Jan;33(1):e7.
- doi: 10.3346/jkms.2018.33.e7
Human epidermal growth factor receptor 2 (HER2) mutation in non-small cell lung cancer (NSCLC) is an oncogenic driver that possibly becomes a druggable target to HER2-targeted therapy. The benefit of... -
- CITED
-
- Close
- SHARE
-
- Close
- Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
-
Kim SS, Cho HJ, Nam JS, Kim HJ, Kang DR, Won JH, Kim J, Kim JK, Lee JH, Kim BH, Lee MY, Cho SW, Cheong JY
- KMID: 2399163
- J Korean Med Sci.
- 2018 Jan;33(1):e6.
- doi: 10.3346/jkms.2018.33.e6
BACKGROUND: We investigated an association between the levels of plasma microRNA (miRNA)-21, -26a, and -29a-3p and treatment outcomes following transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC). METHODS: A total... -
- CITED
-
- Close
- SHARE
-
- Close
- Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation
-
Kim S, Park E, Min SI, Yi NJ, Ha J, Ha IS, Cheong HI, Kang HG
- KMID: 2399161
- J Korean Med Sci.
- 2018 Jan;33(1):e4.
- doi: 10.3346/jkms.2018.33.e4
BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) is a rare disease that is often associated with genetic defects. Mutations of complement factor H (CFH) are the most common genetic defects that... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of Overweight and Income Gaps in 245 Districts of Korea: Comparison Using the National Health Screening Database and the Community Health Survey, 2009–2014
-
Kim I, Bahk J, Kim YY, Lee J, Kang HY, Lee J, Yun SC, Park JH, Shin SA, Khang YH
- KMID: 2399160
- J Korean Med Sci.
- 2018 Jan;33(1):e3.
- doi: 10.3346/jkms.2018.33.e3
BACKGROUND: We compared age-standardized overweight prevalence and their income gaps at the level of district in Korea using the National Health Screening Database (NHSD) and the Community Health Survey (CHS). METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Impacts of Return-to-Work Type and Period on Job Retention in Workers with Occupational Injuries and Diseases
-
Jeong I, Park JB, Kim HR, Yoon JH, Won JU, Roh J
- KMID: 2399159
- J Korean Med Sci.
- 2018 Jan;33(1):e2.
- doi: 10.3346/jkms.2018.33.e2
BACKGROUND: Despite the necessity of job retention in achieving return-to-work (RTW) goals, many workers leave their jobs after returning to work. The objective of this study was to examine the... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and Efficacy of B-domain Deleted Third Generation Recombinant Factor VIII (GreenGene Fâ„¢) in Korean Patients with Hemophilia A: Data from a Post-marketing Surveillance Study
-
Kim SK, Yoo KY, Lee KS, Hwang T, Choi YM, Choi EJ, Park SK
- KMID: 2399162
- J Korean Med Sci.
- 2018 Jan;33(1):e5.
- doi: 10.3346/jkms.2018.33.e5
BACKGROUND: New B-domain deleted third generation recombinant factor VIII (FVIII; GreenGene Fâ„¢, beroctocog alfa) was launched in 2010. We determined safety and efficacy of GreenGene Fâ„¢ during routine clinical practice... -
- CITED
-
- Close
- SHARE
-
- Close
